Mutual Funds & ETF's
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
UK may reject Roche's Avastin for advanced ovarian cancer
Reuters: Company News
Posted on December 17, 2012 at 19:01 PM EST
LONDON, Dec 18 (Reuters) - Britain's healthcare cost-effectiveness watchdog said it may reject Roche Holding AG's drug Avastin for treating advanced ovarian cancer in combination with two standard chemotherapy drugs.
Read More >>
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Bots go here